Comparing Weight-for-Length Status of Young Children in Two Infant Feeding Programs

Heather Aldrich1, Bonnie Gance-Cleveland2

  • 1College of Nursing, University of Colorado Anschutz Medical Campus, 13120 E. 19th Avenue, Aurora, CO, 80045, USA.

Insights

Children in the Nurse-Family Partnership (NFP) and Special Supplemental Program for Women, Infants, and Children (WIC) face high risks of excess weight. NFP participation showed a slight protective effect against high weight-for-length by 24 months.

Area of Science:

  • Pediatric Nutrition
  • Public Health Interventions
  • Childhood Obesity

Background:

  • Infant and toddler populations in early support programs are at risk for high weight-for-length.
  • Understanding growth trajectories within these programs is crucial for public health strategies.
  • Racial/ethnic and socioeconomic disparities impact weight status in early childhood.

Purpose of the Study:

  • To compare the weight-for-length status of children aged 6-24 months enrolled in the Nurse-Family Partnership (NFP) versus the Special Supplemental Program for Women, Infants, and Children (WIC).
  • To evaluate infant and toddler growth trajectories and identify factors associated with high weight-for-length.
  • To assess the impact of program participation on early childhood weight status.

Main Methods:

  • A cross-sectional study utilizing secondary analysis of national NFP and WIC datasets (NFP: n=44,980; WIC: n=31,294).
  • Weight-for-length status calculated at 6, 12, 18, and 24 months using World Health Organization criteria.
  • Binary logistic regression used to determine odds ratios for high weight-for-length (≥97.7 percentile).

Main Results:

  • Approximately 10% of children in both NFP and WIC programs were classified as high weight-for-length at 6 months.
  • High weight-for-length rates increased similarly in both groups until 24 months.
  • At 24 months, NFP children exhibited significantly lower rates of excess weight (15.5%) compared to WIC children (17.5%; P=0.03).
  • Non-Hispanic white children consistently had lower rates of high weight-for-length than Hispanic and non-Hispanic black children.
  • NFP infants demonstrated higher rates of ever being breastfed compared to WIC infants (P < 0.0001).

Conclusions:

  • Both NFP and WIC serve populations at increased risk for high weight-for-length in infants and toddlers.
  • NFP participation was associated with a small but significant protective effect on weight-for-length status at 24 months.
  • Addressing weight-related disparities based on race/ethnicity and socioeconomic status is essential in early childhood interventions.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
687
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
419
Oxygen Requirements and Growth Patterns01:29

Oxygen Requirements and Growth Patterns

Microorganisms exhibit diverse oxygen requirements and growth patterns driven by their metabolic strategies and environmental adaptations. Oxygen, while essential for many organisms, can also be toxic under certain conditions, shaping how microorganisms grow and survive.Oxygen Requirements of MicroorganismsMicroorganisms are classified based on their ability to use or tolerate oxygen:● Obligate aerobes like Mycobacterium tuberculosis need oxygen for energy production, as it serves as the...
2.1K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
641
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
330
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
354